Skip to main content
Clinical Trials/PACTR202408886014501
PACTR202408886014501
Recruiting
Phase 4

The impact of Perioperative Dexmedetomidine usage in prevention of Acute Kidney Injury in patients undergoing Whipple operations ( randomized control study )

national liver institute0 sites50 target enrollmentAugust 5, 2024
ConditionsAnaesthesia

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Anaesthesia
Sponsor
national liver institute
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 5, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients (18 years or older) undergoing Whipple surgery.

Exclusion Criteria

  • Patients with pre\-existing renal dysfunction (eGFR \<60 mL/min/1\.73 m2\)
  • Major intraoperative events (e.g. severe hemodynamic instability, massive blood loss, massive blood products transfusion).
  • Allergy to Dexmedetomidine, unwilling to participate in the study will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials